Prescient Therapeutics (ASX:PTX) - TechKnow Invest Roadshow, August 2023

Interviews

by Finance News Network August 16, 2023 09:14 AM


Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?